General Information of the Compound
Compound ID |
CP0429637
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
2-[6-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]hexyl]-1,1-dioxo-1,2-benzothiazol-3-one
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C24H28N4O3S2
|
||||||||||||||||||
Molecular Weight |
484.647
|
||||||||||||||||||
Canonical SMILES |
O=C1N(CCCCCCN2CCN(CC2)c2nsc3ccccc23)S(=O)(=O)c2ccccc12
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C24H28N4O3S2/c29-24-20-10-4-6-12-22(20)33(30,31)28(24)14-8-2-1-7-13-26-15-17-27(18-16-26)23-19-9-3-5-11-21(19)32-25-23/h3-6,9-12H,1-2,7-8,13-18H2
Show/Hide
|
||||||||||||||||||
InChIKey |
RQRAPENOPIVCKK-UHFFFAOYSA-N
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT01354, 5-hydroxytryptamine receptor 6
Protein ID: PT00941, 5-hydroxytryptamine receptor 7
Protein ID: PT01005, D(2) dopamine receptor